bioAffinity Technologies Inc. (BIAF) Fundamentals

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.
SHARE INFORMATION
Market Cap$ 19,501,518
Shares Outstanding8,369,750
Float6,665,142
Percent Float79.63%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions5
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.8%
Institutional Sold Previous 3 Months-
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months1,385,896
Insider Holdings Percent12.0
Insider Sold Previous 3 Months982,048
Insider Shares Owned1,008,192
TRADING INFO
52 Week High$ 15.55
52 Week Low$ 1.31
52 Week High Change$ 0.00
21 Day Moving Average$ 2.1758
21 Day Extended Moving Average$ 2.2875
50 Day Moving Average$ 2.1481
50 Day Extended Moving Average$ 2.3305
200 Day Moving Average$ 2.7506
200 Day Extended Moving Average$ 4.4813
10 Day Average Volume972,770
20 Day Average Volume3,952,197
30 Day Average Volume2,651,281
50 Day Average Volume1,615,291
Alpha-0.115262
Beta4.4842
Standard Deviation0.432814
R20.426063
7 Day Price Change$ -0.28
7 Day Percent Change-10.73%
21 Day Price Change$ 0.72
21 Day Percent Change44.72%
30 Day Price Change$ 0.73
30 Day Percent Change45.63%
Month to Date Price Change$ -0.28
Month to Date Percent Change-10.73%
Quarter to Date Price Change$ 0.73
Quarter to Date Percent Change45.63%
180 Day Price Change$ 0.00
180 Day Percent Change0.0%
200 Day Price Change$ 0.00
200 Day Percent Change0.0%
Year to Date Price Change$ 0.73
Year to Date Percent Change45.63%

bioAffinity Technologies Inc. (BIAF) Key Ratios

PROFITABILITY
EBIT Margin-365,486.0%
EBITDA Margin-365,337.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin88.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.60
Total Debt To Equity0.10
Int Coverage-2.90
Current Ratio9.60
Leverage Ratio-0.80
Quick Ratio9.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 0
Price to Sales0.00
Price to Free Cash-7.30
PE High Last 5 Years0.00
Price To Book1.60
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.40
Invoice Turnover0.10
Assets Turnover0.00
Return Assets-85.73
Return on Equity-95.70
Return on Capital-76.14

bioAffinity Technologies Inc. (BIAF) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorWithumSmith+Brown, PC
CEOMaria Zannes
Emplyoees14
Last AuditUE
CIK0001712762
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSTesting Laboratories(541380)
CONTACT INFO
Address22211 W Interstate 10
Suite 1206
San Antonio, TX 78257
Websitehttps://www.bioaffinitytech.com
Facsimile-
Telephone+1 210 698-5334
Email-
Your Recent History
NASDAQ
BIAF
bioAffinit..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230208 23:48:44